Login to Your Account



Confirmatory Phase III Prestara Protocol Submitted By Genelabs

By Brady Huggett


Monday, November 18, 2002
Genelabs Technologies Inc. has laid the groundwork for a confirmatory Phase III trial of its lupus drug, Prestara, and said it expects to begin the trial before the end of the year. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription